Closed Clinical Trials

List of articles in category Closed Clinical Trials
Title	Hits
NMDSG07A. A multicentre phase II study of the efficacy and safety of lenalidomide in high-risk myeloid disease (high-risk MDS and AML) with a karyotype including del(5q) or monosomy 5 (NMDSG07A). Published.	Hits: 1841
NMDSG08A. Clinical and biological evaluation of azacitidine in transfusion-dependent patients with low and intermediate-1 risk MDS, and low-risk CMML, who are either refractory to or not eligible for treatment with erythropoietin +/- G-CSF. Published.	Hits: 2706
NMDSG10A. A pilot phase I dose finding safety study of a Thrombopoietin-receptor agonist, Eltrombopag, in patients with Myelodysplastic syndrome treated with Azacitidine (NMDSG10A). Published.	Hits: 1638
NMDSG10B. A multicentre open randomized phase II study of the efficacy and safety of azacitidine alone or in combination with lenalidomide in high-risk myeloid disease (high-risk MDS and AML) with a karyotype including del(5q). Closed.	Hits: 4657

NMDS Group